0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Nanoplastics Sign in to save

Microplastic and nanoplastic pollution and associated potential disease risks

The Lancet Planetary Health 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Nurshad Ali, Jenny Katsouli, Eric Auyang, Jorge Bernardino de la Serna

Summary

This review summarizes evidence on potential health risks from human exposure to micro- and nanoplastics, covering metabolic, respiratory, cardiovascular, neurological, liver, kidney, and skin disorders, as well as cancer and aging-related conditions. Researchers found that while animal and cell studies show numerous adverse effects, direct evidence linking microplastic exposure to human disease remains limited. The study emphasizes the need for better human exposure data and broader investigation of environmentally prevalent plastic types.

Microplastics and nanoplastics (MNPs) are emerging pollutants widely dispersed in the environment, with humans primarily exposed through ingestion and inhalation. Although their biological effects are being increasingly studied, their potential effect on human health and disease risk remains uncertain. This Review summarises evidence on potential disease risks of human exposure to MNPs, while highlighting key limitations and research gaps. Evidence suggests that MNP exposure might elevate the risk of various diseases, including metabolic, respiratory, cardiovascular, neuroendocrine, hepatic, renal, and skin disorders, as well as infectious diseases, cancer, and ageing-related disorders. Despite extensive evidence of adverse effects in animal models and cell cultures, direct evidence linking MNP exposure to human disease risk remains scarce. A key challenge on research of MNPs lies in the scarcity of robust human exposure data and the narrow scope of existing studies on specific types of MNPs, leaving several environmentally prevalent plastic particles understudied. Addressing these gaps will require investigating the mechanisms of toxicity, relevant biomarkers, and disease pathways associated with MNP exposure. Such efforts will be essential to clarify human health risks and inform future regulatory and mitigation strategies.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Impact of microplastics and nanoplastics on human Health: Emerging evidence and future directions

This review summarizes current evidence on how micro- and nanoplastics enter the human body through food, air, and skin contact, and the cellular damage they may cause. While microplastic pollution is a recognized environmental hazard, the authors note that definitive evidence linking plastic particle exposure to specific health outcomes in humans is still limited and more realistic exposure studies are needed.

Review Tier 2

A review of data for quantifying human exposures to micro and nanoplastics and potential health risks

This review synthesizes data on human exposure to micro- and nanoplastics through air, water, and food, and examines the potential health effects. Researchers found evidence of respiratory, liver, immune, and gastrointestinal impacts in humans and mammals exposed to elevated plastic particle levels, with toxicity varying by plastic type and size. The study highlights that while growing evidence links plastic particle exposure to health concerns, significant data gaps remain in quantifying actual human intake and long-term risks.

Review Tier 2

Potential human health risks due to environmental exposure to nano- and microplastics and knowledge gaps: A scoping review

This scoping review surveyed existing research on the potential human health effects of exposure to micro- and nanoplastics. The evidence suggests these particles may contribute to oxidative stress, inflammation, and immune disruption, but the review highlights major knowledge gaps and calls for more studies specifically focused on human health outcomes.

Systematic Review Tier 1

A Systematic Review on the Impact of Micro-Nanoplastics Exposure on Human Health and Diseases

This systematic review summarizes existing research on how micro and nanoplastic exposure affects human health and may contribute to disease. The evidence suggests that these tiny particles can enter the body through food, water, air, and even cosmetics, potentially causing inflammation, oxidative stress, and disruptions to the immune and reproductive systems.

Review Tier 2

Micro- and Nanoplastics as Emerging Environmental Determinants of Human Health: A Narrative Review

This narrative review explores the existing evidence linking micro- and nanoplastic exposure to potential health-related outcomes across multiple organ systems. Researchers found increasing experimental and observational evidence indicating that exposure to these particles may be associated with adverse biological effects. The review highlights the need for further clinical research to understand the full scope of microplastic impacts on human health.

Share this paper